title: Mineralocorticoid deficiency and treatment in congenital adrenal hyperplasia.
abstract: Approximately 75%-80% of patients with Congenital Adrenal Hyperplasia (CAH) fail to synthesize sufficient mineralocorticoids to maintain salt and water balance. In most instances genotype can predict mineralocorticoid deficiency in CAH. Early recognition and replacement with 9alpha-fludrocortisone and salt supplements will prevent development of potentially lethal salt losing crises. In infancy a relative state of aldosterone resistance exists and replacement dose of 9alpha-fludrocortisone based on body surface area is higher during infancy compared to childhood and adults. Salt supplementation is generally not required after weaning is started. Regular monitoring of blood pressure and measurements of plasma electrolytes and renin are required to prevent complications of under or over dosage.
authors.affiliation: London Centre for Paediatric Endocrinology and Metabolism, Great Ormond Street Hospital for Children NHS Trust, London WC1N 3JH, UK.
authors.forename: Raja
authors.initials: R
authors.lastname: Padidela
authors.forename: Peter C
authors.initials: PC
authors.lastname: Hindmarsh
references.citation: Eur J Pediatr. 2005 Mar;164(3):141-5
references.pmid: 15558316
references.citation: Nat Genet. 1992 Jul;1(4):239-45
references.pmid: 1363812
references.citation: J Clin Invest. 1992 Aug;90(2):584-95
references.pmid: 1644925
references.citation: Eur J Pediatr. 1977 Aug 23;126(1-2):86-96
references.pmid: 902665
references.citation: J Clin Endocrinol Metab. 2002 Jul;87(7):3031-7
references.pmid: 12107196
references.citation: Pediatrics. 2006 Jan;117(1):e98-105
references.pmid: 16396852
references.citation: N Engl J Med. 2000 Nov 9;343(19):1362-8
references.pmid: 11070100
references.citation: Endocr Rev. 2000 Jun;21(3):245-91
references.pmid: 10857554
references.citation: Clin Endocrinol (Oxf). 2010 Feb;72(2):155-60
references.pmid: 19508608
references.citation: Clin Biochem Rev. 2009 May;30(2):75-86
references.pmid: 19565027
references.citation: N Engl J Med. 1997 Oct 30;337(18):1285-92
references.pmid: 9345079
references.citation: Clin Endocrinol (Oxf). 2003 May;58(5):589-96
references.pmid: 12699440
references.citation: Best Pract Res Clin Endocrinol Metab. 2009 Apr;23(2):167-79
references.pmid: 19500761
references.citation: Proc Natl Acad Sci U S A. 1984 Dec;81(23):7505-9
references.pmid: 6334310
references.citation: Pediatr Res. 1980 Jan;14(1):39-46
references.pmid: 7360520
references.citation: Best Pract Res Clin Endocrinol Metab. 2009 Apr;23(2):193-208
references.pmid: 19500763
references.citation: J Clin Endocrinol Metab. 1991 Nov;73(5):969-74
references.pmid: 1939534
references.citation: J Clin Endocrinol Metab. 2002 May;87(5):2114-20
references.pmid: 11994350
references.citation: Rev Endocr Metab Disord. 2007 Dec;8(4):349-63
references.pmid: 17885806
references.citation: Endocr Rev. 2005 Jun;26(4):525-82
references.pmid: 15632317
references.citation: Pediatr Res. 2009 Sep;66(3):323-8
references.pmid: 19542911
references.citation: J Clin Endocrinol Metab. 2000 Mar;85(3):1059-65
references.pmid: 10720040
references.citation: Horm Res. 2002;58(4):196-205
references.pmid: 12324719
references.citation: J Clin Endocrinol Metab. 2007 Jan;92(1):137-42
references.pmid: 17032723
references.citation: Steroids. 1996 Apr;61(4):166-71
references.pmid: 8732994
references.citation: J Clin Endocrinol Metab. 1997 Oct;82(10):3293-7
references.pmid: 9329356
references.citation: J Clin Endocrinol Metab. 1995 Aug;80(8):2322-9
references.pmid: 7629224
references.citation: J Clin Endocrinol Metab. 1994 May;78(5):1145-52
references.pmid: 8175971